Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio Caballero

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Mini Reviews in Medicinal Chemistry|January 1, 2020
Transforming Non-Selective Angiotensin-Converting Enzyme Inhibitors in C- and N-domain Selective Inhibitors by Using Computational ToolsSergio Alfaro, Carlos Navarro-Retamal, Julio Caballero
Journal of Molecular Modeling|October 9, 2024
Shannon entropy variation as a global indicator of electron density contraction at interatomic regions in chemical reactionsCésar Barrales-Martínez, Rocío Durán, Julio Caballero
Molecular Diversity|March 23, 2010
Genetic algorithm optimization in drug design QSAR: Bayesian-regularized genetic neural networks (BRGNN) and genetic algorithm-optimized support vectors machines (GA-SVM)Michael Fernandez, Julio Caballero, Leyden Fernandez, et al.
Journal of Molecular Modeling|May 29, 2015
Understanding the comparative molecular field analysis (CoMFA) in terms of molecular quantum similarity and DFT-based reactivity descriptorsAlejandro Morales-Bayuelo, Ricardo A Matute, Julio Caballero
Bioorganic & Medicinal Chemistry|March 25, 2008
A CoMSIA study on the adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analoguesJulio Caballero, Michael Fernández, Fernando D González-Nilo
Bioorganic & Medicinal Chemistry|May 13, 2008
Structural requirements of pyrido[2,3-d]pyrimidin-7-one as CDK4/D inhibitors: 2D autocorrelation, CoMFA and CoMSIA analysesJulio Caballero, Michael Fernández, Fernando D González-Nilo
Journal of Computer-Aided Molecular Design|October 28, 2018
Mycobacterium tuberculosis serine/threonine protein kinases: structural information for the design of their specific ATP-competitive inhibitorsJulio Caballero, Alejandro Morales-Bayuelo, Carlos Navarro-Retamal
Chemical Biology & Drug Design|February 23, 2007
Quantitative structure-activity relationship modeling of growth hormone secretagogues agonist activity of some tetrahydroisoquinoline 1-carboxamidesJulio Caballero, Fabio M Zampini, Simona Collina, et al.
Frontiers in Molecular Biosciences|July 10, 2023
Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-dockingLuis Castillo-Campos, José Luis Velázquez-Libera, Julio Caballero
International Journal of Molecular Sciences|October 3, 2018
Insights into the Structural Requirements of 2(S)-Amino-6-Boronohexanoic Acid Derivatives as Arginase I Inhibitors: 3D-QSAR, Docking, and Interaction Fingerprint StudiesJosé Luis Velázquez-Libera, Carlos Navarro-Retamal, Julio Caballero
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Mini Reviews in Medicinal Chemistry|January 1, 2020
Transforming Non-Selective Angiotensin-Converting Enzyme Inhibitors in C- and N-domain Selective Inhibitors by Using Computational ToolsSergio Alfaro, Carlos Navarro-Retamal, Julio Caballero
Journal of Molecular Modeling|October 9, 2024
Shannon entropy variation as a global indicator of electron density contraction at interatomic regions in chemical reactionsCésar Barrales-Martínez, Rocío Durán, Julio Caballero
Molecular Diversity|March 23, 2010
Genetic algorithm optimization in drug design QSAR: Bayesian-regularized genetic neural networks (BRGNN) and genetic algorithm-optimized support vectors machines (GA-SVM)Michael Fernandez, Julio Caballero, Leyden Fernandez, et al.
Journal of Molecular Modeling|May 29, 2015
Understanding the comparative molecular field analysis (CoMFA) in terms of molecular quantum similarity and DFT-based reactivity descriptorsAlejandro Morales-Bayuelo, Ricardo A Matute, Julio Caballero
Bioorganic & Medicinal Chemistry|March 25, 2008
A CoMSIA study on the adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analoguesJulio Caballero, Michael Fernández, Fernando D González-Nilo
Bioorganic & Medicinal Chemistry|May 13, 2008
Structural requirements of pyrido[2,3-d]pyrimidin-7-one as CDK4/D inhibitors: 2D autocorrelation, CoMFA and CoMSIA analysesJulio Caballero, Michael Fernández, Fernando D González-Nilo
Journal of Computer-Aided Molecular Design|October 28, 2018
Mycobacterium tuberculosis serine/threonine protein kinases: structural information for the design of their specific ATP-competitive inhibitorsJulio Caballero, Alejandro Morales-Bayuelo, Carlos Navarro-Retamal
Chemical Biology & Drug Design|February 23, 2007
Quantitative structure-activity relationship modeling of growth hormone secretagogues agonist activity of some tetrahydroisoquinoline 1-carboxamidesJulio Caballero, Fabio M Zampini, Simona Collina, et al.
Frontiers in Molecular Biosciences|July 10, 2023
Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-dockingLuis Castillo-Campos, José Luis Velázquez-Libera, Julio Caballero
International Journal of Molecular Sciences|October 3, 2018
Insights into the Structural Requirements of 2(S)-Amino-6-Boronohexanoic Acid Derivatives as Arginase I Inhibitors: 3D-QSAR, Docking, and Interaction Fingerprint StudiesJosé Luis Velázquez-Libera, Carlos Navarro-Retamal, Julio Caballero
Pageof 14